EP Europace

1. Europace10 Jul 2023

   Effect of fibrosis regionality on atrial fibrillation recurrence: insights from DECAAF II

   Secondary analysisArrhythmias & EP

2. Europace8 Jul 2023

   Arrhythmogenic vulnerability of re-entrant pathways in post-infarct ventricular tachycardia assessed by advanced computational modelling

   Cohort studyArrhythmias & EP

3. Europace7 Jul 2023

   Very-early symptomatic recurrence is associated with late recurrence after radiofrequency ablation of atrial fibrillation

   Cohort studyArrhythmias & EP

4. Europace3 Jul 2023

   Delineation of conduction gaps of linear lesions during atrial fibrillation ablation using ultra-high-density mapping

   Cohort studyArrhythmias & EP

5. Europace1 Jul 2023

   Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study

   Cohort studyHeart failure

6. Europace28 Jun 2023

   EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry

   Cohort studyArrhythmias & EP

7. Europace27 Jun 2023

   Bayesian analysis of the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia trial

   Secondary analysisArrhythmias & EP

8. Europace21 Jun 2023

   Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials

   Meta-analysisArrhythmias & EP

All 488 Briefs in ExploreShowing Briefs 481–488 of 488, newest first